The American Diabetes Association guidelines specify that “major clinical trials of insulin-treated patients that demonstrated the benefits of intensive glycemic control on diabetes complications have included self-monitoring of blood glucose (SMBG) as part of multifactorial interventions, suggesting that SMBG is a component of effective therapy” [1]. Here, INS is linked to diabetes mellitus.